Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Clin |
RCV004699116 | SCV005201059 | uncertain significance | Monogenic diabetes | 2024-08-01 | reviewed by expert panel | curation | The c.1747C>G variant in the e.g. HNF1 homeobox A gene, HNF1A, causes an amino acid change of arginine to glycine at codon 583 (p.(Arg583Gly)) of NM_000545.8. This variant has an incomputable gnomAD v2.1.1 Grpmax filtering allele frequency due to 0 copies in the European non-Finnish subpopulation and 1 copy in the East Asian subpopulation, thereby meeting the ClinGen MDEP threshold criteria for PM2_Supporting (ENF Grpmax FAF <= 0.000003 and <= 2 copies in ENF and <=1 copy in any other subpopulation) (PM2_Supporting). This variant was identified in an individual(s) with diabetes; however, the calculated MODY probability is <50% and HNF4A was not tested (PMID: 9313763). This variant segregated with diabetes with 1 informative meiosis in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMID: 27236918, 9313763). In summary, c.1747C>G meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 2.1.0 approved 8/11/2023): PM2_Supporting. |
| Illumina Laboratory Services, |
RCV000030492 | SCV001269891 | uncertain significance | Maturity-onset diabetes of the young type 3 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
| Labcorp Genetics |
RCV002514104 | SCV003447879 | uncertain significance | not provided | 2022-08-24 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs137853239, gnomAD 0.006%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 14932). This missense change has been observed in individuals with diabetes (PMID: 9313763, 11942313, 12355088, 21236713). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 583 of the HNF1A protein (p.Arg583Gly). |
| OMIM | RCV000016069 | SCV000036337 | pathogenic | Type 1 diabetes mellitus 20 | 1997-10-01 | no assertion criteria provided | literature only | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030492 | SCV000053162 | not provided | Maturity-onset diabetes of the young type 3 | 2015-10-02 | no assertion provided | clinical testing |